0 results available. Select is focused ,type to refine list, press Down to open the menu,
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, In...
The following section summarizes insights on Johnson & Johnson's Cost of Revenue Growth:
We've identified the following companies as similar to Johnson & Johnson because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Cost of Revenue Growth in the growth category include:
Period over prior period growth in cost of revenue.
The cost of goods sold growth measures a company’s cost of goods sold year-over-year growth. The formula to calculate cost of revenue growth and an example calculation for Johnson & Johnson’s trailing twelve months is outlined below:
Cost of Revenue Growth = (Current Year - Prior Year) / ABS(Prior Year Cost of Goods Sold)*
6.9% = ($27.883 B - $26.075 B) / $26.075 B
*ABS = An absolute value adjustment is used to ensure the direction of growth of negative numbers is reflected
The tables below summarizes Johnson & Johnson’s performance over the last five years:
| Fiscal Year | Cost of Goods Sold | Growth |
|---|---|---|
| 2021-01-03 | 28.427 B | 3.2% |
| 2022-01-02 | 23.402 B | −17.7% |
| 2023-01-01 | 24.596 B | 5.1% |
| 2023-12-31 | 26.044 B | 5.9% |
| 2024-12-29 | 27.036 B | 3.8% |
The tables below summarizes Johnson & Johnson’s performance over the last four quarters:
| Quarter Ending | Cost of Goods Sold | Growth |
|---|---|---|
| 2024-06-30 | 6.867 B | 6.3% |
| 2024-09-29 | 6.757 B | 5.9% |
| 2024-12-29 | 6.908 B | 6.0% |
| 2025-03-30 | 7.365 B | 13.0% |
Growth calculations are always made in the company’s reporting currency to ensure currency fluctuations do not impact the calculation. Johnson & Johnson’s reports in the USD currency. You can read more about Cost of Goods Sold here.
The chart above depicts the distribution of cost of revenue growth for companies operating in the Healthcare sector in the Developed economic region. Over 1,730 companies were considered in this analysis, and 1,668 had meaningful values. The average cost of revenue growth of companies in the sector is 16.3% with a standard deviation of 63.6%.
Johnson & Johnson's Cost of Revenue Growth of 6.9% ranks in the 54.2% percentile for the sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 1,738 |
| Included Constituents | 1,668 |
| Min | -85.7% |
| Max | 548.4% |
| Median | 5.3% |
| Mean | 16.3% |
| Standard Deviation | 63.6% |
You can find companies with similar cost of revenue growth using this stock screener.